Waterloo Capital’s Hims & Hers Health HIMS Stock Holding History

Waterloo Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,900	Closed	-$221K	–	469
2025 Q3	$221K	Buy	+3,900	New	+$200K	0.02%	424

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Waterloo Capital's HIMS Position: Q4 2025 in Review

Waterloo Capital sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 3,900 shares — an estimated $221K sold.

Waterloo Capital first reported a position in HIMS in Q3 2025 and held it in 1 quarter. The position peaked at $221K in Q3 2025. 485 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

Waterloo Capital reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
Waterloo Capital sold 3,900 Hims & Hers Health shares in Q4 2025, an estimated $221K.
Waterloo Capital first reported a position in Hims & Hers Health in Q3 2025 and held it in 1 quarter.
Waterloo Capital's Hims & Hers Health position peaked at $221K in Q3 2025.
485 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Waterloo Capital's 13F filing for Q4 2025, filed 10 Feb 2026.